{"title":"Metabolic Research","description":"","products":[{"product_id":"retatrutide","title":"Retatrutide 10mg","description":"\u003cp\u003eRetatrutide (LY3437943) is a synthetic peptide analogue designed as a triple-hormone receptor agonist. Unlike single or dual agonists, Retatrutide exhibits high affinity for three distinct receptors: the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor, and the glucagon (GCG) receptor.Scientific investigation of Retatrutide focuses on its biochemical interactions with pancreatic beta-cells, hepatocytes, and adipocytes. Research aims to understand its impact on glucose metabolism, lipid oxidation, and energy homeostasis. All discussion herein is limited strictly to in-vitro and in-vivo animal research contexts and does not imply clinical, cosmetic, or therapeutic use.\u003c\/p\u003e","brand":"p1peptides","offers":[{"title":"10mg","offer_id":52486721896632,"sku":"9351648004495","price":230.0,"currency_code":"USD","in_stock":true},{"title":"20mg","offer_id":52486721962168,"sku":"9351648004501","price":400.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0932\/8790\/7512\/files\/variant-7.jpg?v=1771485390"},{"product_id":"semaglutide","title":"Semaglutide 10mg","description":"\u003cp\u003eSemaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist sharing 94% sequence homology with native human GLP-1. It is chemically modified to include a C18 fatty diacid side chain and specific amino acid substitutions that confer resistance to dipeptidyl peptidase-4 (DPP-4) enzymatic degradation.\u003c\/p\u003e\n\u003cp\u003eScientific investigation of Semaglutide focuses on its biochemical interactions with pancreatic beta-cells, insulin signaling pathways, and central nervous system receptors involved in appetite regulation. All discussion herein is limited strictly to in-vitro and in-vivo animal research contexts and does not imply clinical, cosmetic, or therapeutic use.\u003cstrong\u003e\u003c\/strong\u003e\u003c\/p\u003e","brand":"p1peptides","offers":[{"title":"10mg","offer_id":52486888456376,"sku":"9351648004518","price":255.0,"currency_code":"USD","in_stock":true},{"title":"20mg","offer_id":52486888521912,"sku":"9351648004525","price":430.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0932\/8790\/7512\/files\/variant-9.jpg?v=1771485802"},{"product_id":"retatrutide-20mg","title":"Retatrutide 20mg","description":"\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eHere's your Retatrutide short version rewrite, ready to paste:\u003c\/p\u003e\n\u003chr class=\"border-border-200 border-t-0.5 my-3 mx-1.5\"\u003e\n\u003ch3 class=\"text-text-100 mt-3 -mb-1 text-[1.125rem] font-bold\"\u003eRetatrutide (LY3437943) — Product Page Content (Short Version)\u003c\/h3\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eProduct Title:\u003c\/strong\u003e Retatrutide (LY3437943) — Synthetic Triple Hormone Receptor Agonist Research Peptide (GIP\/GLP-1\/GCG)\u003c\/p\u003e\n\u003chr class=\"border-border-200 border-t-0.5 my-3 mx-1.5\"\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eShort Description:\u003c\/strong\u003e A synthetic peptide analog investigated as a triple hormone receptor agonist with high affinity for GIP, GLP-1, and glucagon receptors. Studied in preclinical research for glucose metabolism pathway dynamics, lipid oxidation mechanisms, and energy homeostasis endpoint modeling. ≥99% Purity, HPLC-Verified. Third-Party CoA Included. For in-vitro laboratory research use only.\u003c\/p\u003e\n\u003chr class=\"border-border-200 border-t-0.5 my-3 mx-1.5\"\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eFull Product Description:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eRetatrutide (LY3437943) is a synthetic peptide analog designed as a triple hormone receptor agonist for controlled laboratory research applications. Unlike single or dual incretin receptor agonists, Retatrutide exhibits high affinity for three distinct receptor targets — the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor, and the glucagon (GCG) receptor — making it a uniquely comprehensive investigative tool for multi-receptor incretin signaling research.\u003c\/p\u003e\n\u003chr class=\"border-border-200 border-t-0.5 my-3 mx-1.5\"\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eMolecular Characteristics \u0026amp; Research Applications\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eScientific investigation of Retatrutide in controlled laboratory settings focuses on its biochemical interactions across several key cellular systems and molecular pathways, including:\u003c\/p\u003e\n\u003cul class=\"[li_\u0026amp;]:mb-0 [li_\u0026amp;]:mt-1 [li_\u0026amp;]:gap-1 [\u0026amp;:not(:last-child)_ul]:pb-1 [\u0026amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\"\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eTriple GIP\/GLP-1\/GCG receptor co-agonism and multi-receptor incretin signaling dynamics\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003ePancreatic beta-cell function and glucose-dependent insulin secretion pathway modeling\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eHepatocyte signaling pathway activity and liver metabolism endpoint research\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eAdipocyte biology and lipid metabolism pathway investigation\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eGlucose metabolism regulation and glycemic control pathway dynamics\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eLipid oxidation mechanism research in controlled preclinical experimental systems\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eEnergy homeostasis pathway modeling and metabolic substrate utilization endpoints\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eComparative multi-receptor versus dual and single receptor agonism pathway studies\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eThese molecular characteristics position Retatrutide as a valuable investigative tool for elucidating the mechanistic basis of triple incretin receptor targeting across multiple metabolic research paradigms in controlled laboratory environments.\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eAll research applications are strictly confined to in-vitro and in-vivo animal research contexts and do not imply clinical, cosmetic, or therapeutic use of any kind.\u003c\/p\u003e\n\u003chr class=\"border-border-200 border-t-0.5 my-3 mx-1.5\"\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003ePurity \u0026amp; Quality\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul class=\"[li_\u0026amp;]:mb-0 [li_\u0026amp;]:mt-1 [li_\u0026amp;]:gap-1 [\u0026amp;:not(:last-child)_ul]:pb-1 [\u0026amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\"\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003e≥99% Purity — HPLC Verified\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eIndependently tested by accredited third-party laboratory\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eCertificate of Analysis (CoA) available for every batch\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr class=\"border-border-200 border-t-0.5 my-3 mx-1.5\"\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eResearch Use Only (RUO) Notice\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eAll products are furnished strictly for in-vitro laboratory research use only. These materials are not medicines or drugs and have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) to diagnose, treat, cure, or prevent any disease or medical condition. Introduction into humans or animals is strictly prohibited. Not for human, medical, diagnostic, or veterinary use.\u003c\/p\u003e","brand":"p1peptides","offers":[{"title":"10mg","offer_id":52862299799736,"sku":"9351648004495","price":230.0,"currency_code":"USD","in_stock":true},{"title":"20mg","offer_id":52862299832504,"sku":"9351648004501","price":400.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0932\/8790\/7512\/files\/gpt-image-1.5-high-fidelity_a_CAN_U_CHANGE_THE_RET.png?v=1771485390"},{"product_id":"semaglutide-20mg","title":"Semaglutide 20mg","description":"\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eSemaglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist sharing 94% sequence homology with native human GLP-1. It is chemically modified to include a C18 fatty diacid side chain and specific amino acid substitutions that confer resistance to dipeptidyl peptidase-4 (DPP-4) enzymatic degradation, making it a stable and reproducible tool compound for controlled laboratory research applications.\u003c\/p\u003e\n\u003chr class=\"border-border-200 border-t-0.5 my-3 mx-1.5\"\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eMolecular Characteristics \u0026amp; Research Applications\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eScientific investigation of Semaglutide in controlled laboratory settings focuses on its biochemical interactions across several key molecular systems, including:\u003c\/p\u003e\n\u003cul class=\"[li_\u0026amp;]:mb-0 [li_\u0026amp;]:mt-1 [li_\u0026amp;]:gap-1 [\u0026amp;:not(:last-child)_ul]:pb-1 [\u0026amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\"\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eGLP-1 receptor binding dynamics and incretin signaling pathway activity\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003ePancreatic beta-cell function and glucose-dependent insulin secretion pathway modeling\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eDPP-4 enzymatic degradation resistance mechanisms and pharmacokinetic stability research\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eInsulin signaling pathway activity and downstream metabolic cascade investigation\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eCentral nervous system receptor interaction studies relevant to appetite regulation pathway research\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eComparative incretin receptor agonism studies in preclinical metabolic research models\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eGlycemic regulation endpoint modeling in controlled experimental systems\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eAll research applications are strictly confined to in-vitro and in-vivo animal research contexts. No clinical, cosmetic, or therapeutic use is implied or intended.\u003c\/p\u003e\n\u003chr class=\"border-border-200 border-t-0.5 my-3 mx-1.5\"\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003ePurity \u0026amp; Quality\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul class=\"[li_\u0026amp;]:mb-0 [li_\u0026amp;]:mt-1 [li_\u0026amp;]:gap-1 [\u0026amp;:not(:last-child)_ul]:pb-1 [\u0026amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\"\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003e≥99% Purity — HPLC Verified\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eIndependently tested by accredited third-party laboratory\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eCertificate of Analysis (CoA) available for every batch\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr class=\"border-border-200 border-t-0.5 my-3 mx-1.5\"\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eResearch Use Only (RUO) Notice\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eAll products are furnished strictly for in-vitro laboratory research use only. These materials are not medicines or drugs and have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) to diagnose, treat, cure, or prevent any disease or medical condition. Introduction into humans or animals is strictly prohibited. Not for human, medical, diagnostic, or veterinary use.\u003c\/p\u003e","brand":"p1peptides","offers":[{"title":"10mg","offer_id":52862310711480,"sku":"9351648004518","price":255.0,"currency_code":"USD","in_stock":true},{"title":"20mg","offer_id":52862310744248,"sku":"9351648004525","price":430.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0932\/8790\/7512\/files\/a_CAN_U_CHANGE_in_the.png?v=1771485802"},{"product_id":"tirzepatide-10mg","title":"Tirzepatide 10mg","description":"\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eTirzepatide is a laboratory-synthesized 39-amino acid synthetic peptide functioning as a unimolecular dual agonist of both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. It is structurally based on the native GIP sequence with targeted modifications — including a C20 fatty diacid acyl chain attached via a linker at position 20 — conferring an extended plasma half-life of approximately 5 days and balanced co-agonism (GIPR:GLP-1R potency ratio ≈ 5:1 in vitro, with near-native GIP potency and approximately 20% GLP-1 potency relative to native ligands).\u003c\/p\u003e\n\u003chr class=\"border-border-200 border-t-0.5 my-3 mx-1.5\"\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eMolecular Characteristics \u0026amp; Research Applications\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eThrough simultaneous activation of both incretin receptors in controlled laboratory settings, Tirzepatide serves as an investigative research tool for studying dual incretin receptor signaling mechanisms and their downstream metabolic pathway effects. Key research applications include:\u003c\/p\u003e\n\u003cul class=\"[li_\u0026amp;]:mb-0 [li_\u0026amp;]:mt-1 [li_\u0026amp;]:gap-1 [\u0026amp;:not(:last-child)_ul]:pb-1 [\u0026amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\"\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eDual GIP\/GLP-1 receptor co-agonism and incretin signaling pathway dynamics\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eGlycemic regulation mechanism research and glucose homeostasis pathway modeling\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eComparative incretin pathway analysis versus selective GLP-1 receptor agonism in preclinical systems\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eCardiometabolic endpoint modeling and metabolic pathway investigation\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eType 2 diabetes experimental model research\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eMetabolic dysfunction-associated steatotic liver disease (MASLD) pathway investigation\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eObesity-related comorbidity endpoint modeling in controlled preclinical systems\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eThese molecular characteristics position Tirzepatide as a valuable investigative tool for elucidating the mechanistic basis of dual incretin receptor targeting across multiple metabolic research paradigms in controlled laboratory environments.\u003c\/p\u003e\n\u003chr class=\"border-border-200 border-t-0.5 my-3 mx-1.5\"\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003ePurity \u0026amp; Quality\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul class=\"[li_\u0026amp;]:mb-0 [li_\u0026amp;]:mt-1 [li_\u0026amp;]:gap-1 [\u0026amp;:not(:last-child)_ul]:pb-1 [\u0026amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\"\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003e≥99% Purity — HPLC Verified\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eIndependently tested by accredited third-party laboratory\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eCertificate of Analysis (CoA) available for every batch\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr class=\"border-border-200 border-t-0.5 my-3 mx-1.5\"\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eResearch Use Only (RUO) Notice\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eAll products are furnished strictly for in-vitro laboratory research use only. These materials are not medicines or drugs and have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) to diagnose, treat, cure, or prevent any disease or medical condition. Introduction into humans or animals is strictly prohibited. Not for human, medical, diagnostic, or veterinary use.\u003c\/p\u003e","brand":"p1peptides","offers":[{"title":"10mg","offer_id":52862329618616,"sku":"9351648004549","price":200.0,"currency_code":"USD","in_stock":true},{"title":"20mg","offer_id":52862329651384,"sku":"9351648004556","price":340.0,"currency_code":"USD","in_stock":true},{"title":"40mg","offer_id":52862329684152,"sku":"9351648004556","price":600.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0932\/8790\/7512\/files\/gpt-image-1.5-high-fidelity_a_CAN_U_CHANGE_in_the.png?v=1771486905"},{"product_id":"tirzepatide-20mg","title":"Tirzepatide 20mg","description":"\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eTirzepatide is a laboratory-synthesized 39-amino acid synthetic peptide functioning as a unimolecular dual agonist of both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. It is structurally based on the native GIP sequence with targeted modifications — including a C20 fatty diacid acyl chain attached via a linker at position 20 — conferring an extended plasma half-life of approximately 5 days and balanced co-agonism (GIPR:GLP-1R potency ratio ≈ 5:1 in vitro, with near-native GIP potency and approximately 20% GLP-1 potency relative to native ligands).\u003c\/p\u003e\n\u003chr class=\"border-border-200 border-t-0.5 my-3 mx-1.5\"\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eMolecular Characteristics \u0026amp; Research Applications\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eThrough simultaneous activation of both incretin receptors in controlled laboratory settings, Tirzepatide serves as an investigative research tool for studying dual incretin receptor signaling mechanisms and their downstream metabolic pathway effects. Key research applications include:\u003c\/p\u003e\n\u003cul class=\"[li_\u0026amp;]:mb-0 [li_\u0026amp;]:mt-1 [li_\u0026amp;]:gap-1 [\u0026amp;:not(:last-child)_ul]:pb-1 [\u0026amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\"\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eDual GIP\/GLP-1 receptor co-agonism and incretin signaling pathway dynamics\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eGlycemic regulation mechanism research and glucose homeostasis pathway modeling\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eComparative incretin pathway analysis versus selective GLP-1 receptor agonism in preclinical systems\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eCardiometabolic endpoint modeling and metabolic pathway investigation\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eType 2 diabetes experimental model research\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eMetabolic dysfunction-associated steatotic liver disease (MASLD) pathway investigation\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eObesity-related comorbidity endpoint modeling in controlled preclinical systems\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eThese molecular characteristics position Tirzepatide as a valuable investigative tool for elucidating the mechanistic basis of dual incretin receptor targeting across multiple metabolic research paradigms in controlled laboratory environments.\u003c\/p\u003e\n\u003chr class=\"border-border-200 border-t-0.5 my-3 mx-1.5\"\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003ePurity \u0026amp; Quality\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul class=\"[li_\u0026amp;]:mb-0 [li_\u0026amp;]:mt-1 [li_\u0026amp;]:gap-1 [\u0026amp;:not(:last-child)_ul]:pb-1 [\u0026amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\"\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003e≥99% Purity — HPLC Verified\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eIndependently tested by accredited third-party laboratory\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eCertificate of Analysis (CoA) available for every batch\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr class=\"border-border-200 border-t-0.5 my-3 mx-1.5\"\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eResearch Use Only (RUO) Notice\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eAll products are furnished strictly for in-vitro laboratory research use only. These materials are not medicines or drugs and have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) to diagnose, treat, cure, or prevent any disease or medical condition. Introduction into humans or animals is strictly prohibited. Not for human, medical, diagnostic, or veterinary use.\u003c\/p\u003e","brand":"p1peptides","offers":[{"title":"10mg","offer_id":52862330273976,"sku":"9351648004549","price":200.0,"currency_code":"USD","in_stock":true},{"title":"20mg","offer_id":52862330306744,"sku":"9351648004556","price":340.0,"currency_code":"USD","in_stock":true},{"title":"40mg","offer_id":52862330339512,"sku":"9351648004693","price":600.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0932\/8790\/7512\/files\/variant-13.jpg?v=1771486905"},{"product_id":"tirzepatide-40mg","title":"Tirzepatide 40mg","description":"\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eTirzepatide is a laboratory-synthesized 39-amino acid synthetic peptide functioning as a unimolecular dual agonist of both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. It is structurally based on the native GIP sequence with targeted modifications — including a C20 fatty diacid acyl chain attached via a linker at position 20 — that confer an extended plasma half-life of approximately 5 days and balanced co-agonism (GIPR:GLP-1R potency ratio ≈ 5:1 in vitro, with near-native GIP potency and approximately 20% GLP-1 potency relative to native ligands).\u003c\/p\u003e\n\u003chr class=\"border-border-200 border-t-0.5 my-3 mx-1.5\"\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eMolecular Characteristics \u0026amp; Research Applications\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eThrough simultaneous activation of both incretin receptors in controlled laboratory settings, Tirzepatide serves as a research tool for investigating dual incretin receptor signaling dynamics and their downstream metabolic pathway effects. Key research applications include examination of the following molecular systems and experimental endpoints:\u003c\/p\u003e\n\u003cul class=\"[li_\u0026amp;]:mb-0 [li_\u0026amp;]:mt-1 [li_\u0026amp;]:gap-1 [\u0026amp;:not(:last-child)_ul]:pb-1 [\u0026amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\"\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eDual GIP\/GLP-1 receptor co-agonism and incretin signaling pathway dynamics\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eGlycemic regulation mechanisms and glucose-dependent insulinotropic pathway activity\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eComparative analysis of dual incretin targeting versus selective GLP-1 receptor agonism\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eCardiometabolic pathway endpoint modeling in preclinical research systems\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eBody composition and energy homeostasis pathway investigations\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eType 2 diabetes experimental model research\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eMetabolic dysfunction-associated steatotic liver disease (MASLD) pathway investigation\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eObesity-related comorbidity endpoint modeling in controlled animal systems\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eThese molecular characteristics position Tirzepatide as a valuable investigative tool for elucidating the mechanistic basis of dual incretin receptor targeting across multiple metabolic research paradigms.\u003c\/p\u003e\n\u003chr class=\"border-border-200 border-t-0.5 my-3 mx-1.5\"\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003ePurity \u0026amp; Quality\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul class=\"[li_\u0026amp;]:mb-0 [li_\u0026amp;]:mt-1 [li_\u0026amp;]:gap-1 [\u0026amp;:not(:last-child)_ul]:pb-1 [\u0026amp;:not(:last-child)_ol]:pb-1 list-disc flex flex-col gap-1 pl-8 mb-3\"\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003e≥99% Purity — HPLC Verified\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eIndependently tested by accredited third-party laboratory\u003c\/li\u003e\n\u003cli class=\"font-claude-response-body whitespace-normal break-words pl-2\"\u003eCertificate of Analysis (CoA) available for every batch\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr class=\"border-border-200 border-t-0.5 my-3 mx-1.5\"\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003e\u003cstrong\u003eResearch Use Only (RUO) Notice\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"font-claude-response-body break-words whitespace-normal leading-[1.7]\"\u003eAll products are furnished strictly for in-vitro laboratory research use only. These materials are not medicines or drugs and have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) to diagnose, treat, cure, or prevent any disease or medical condition. Introduction into humans or animals is strictly prohibited. Not for human, medical, diagnostic, or veterinary use.\u003c\/p\u003e","brand":"p1peptides","offers":[{"title":"10mg","offer_id":52862330863800,"sku":"9351648004556","price":200.0,"currency_code":"USD","in_stock":true},{"title":"20mg","offer_id":52862330896568,"sku":"9351648004549","price":340.0,"currency_code":"USD","in_stock":true},{"title":"40mg","offer_id":52862330929336,"sku":"9351648004693","price":600.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0932\/8790\/7512\/files\/gpt-image-1.5-high-fidelity_a_CAN_U_CHANGE_in_the__1.png?v=1771486905"}],"url":"https:\/\/p1peptides.com\/collections\/healing-recovery-injury-repair-copy.oembed","provider":"p1peptides","version":"1.0","type":"link"}